387
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Effects of Respiratory Training Combined with Limb Exercise on Pulmonary Function and Quality of Life in Patients with Bronchiectasis

, , &
Pages 475-482 | Received 06 Sep 2022, Accepted 12 Dec 2022, Published online: 22 Feb 2023

References

  • Polverino E, Goeminne PC, McDonnell MJ, et al. European respiratory society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50:1700629. doi:10.1183/13993003.00629-2017
  • Chan CH, Ho AK, Chan RC, Cheung H, Cheng AF. Mycobacteria as a cause of infective exacerbation in bronchiectasis. Postgrad Med J. 1992;68:896–899. doi:10.1136/pgmj.68.805.896
  • Ekanayake A, Madegedara D, Chandrasekharan V, Magana-Arachchi D. Respiratory bacterial microbiota and individual bacterial variability in lung cancer and bronchiectasis patients. Indian J Microbiol. 2020;60:196–205. doi:10.1007/s12088-019-00850-w
  • Tiew PY, Lim AYH, Keir HR, et al. High frequency of allergic bronchopulmonary aspergillosis in bronchiectasis-COPD overlap. Chest. 2021;S0012–3692(21):3620. doi:10.1016/j.chest.2021.07.2165
  • Tiew PY, Jaggi TK, Chan LLY, Chotirmall SH. The airway microbiome in COPD, bronchiectasis and bronchiectasis-COPD overlap. Clin Respir J. 2021;15:123–133. doi:10.1111/crj.13294
  • Nowiński A, Korzybski D, Bednarek M, Goljan-Geremek A, Puścińska E, Śliwiński P. Does bronchiectasis affect COPD comorbidities? Adv Respir Med. 2019;87:214–220. doi:10.5603/ARM.2019.0059
  • Jin M, Yu WL, Li SL, Lu LJ, Liu XF, Sun YC. Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease. Medicine. 2016;95:e4219. doi:10.1097/MD.0000000000004219
  • Quint JK, Millett ERC, Joshi M, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J. 2016;47:186–193. doi:10.1183/13993003.01033-2015
  • Sidhu MK, Mandal P, Hill AT. Developing drug therapies in bronchiectasis. Expert Opin Investig Drugs. 2015;24:169–181. doi:10.1517/13543784.2015.971153
  • Tsang KW, Bilton D. Clinical challenges in managing bronchiectasis. Respirology. 2009;14:637–650. doi:10.1111/j.1440-1843.2009.01569.x
  • Gillham MI, Sundaram S, Laughton CR, Haworth CS, Bilton D, Foweraker JE. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis. J Antimicrob Chemother. 2009;63:728–732. doi:10.1093/jac/dkp007
  • Liaw MY, Wang YH, Tsai YC, et al. Inspiratory muscle training in bronchiectasis patients: a prospective randomized controlled study. Clin Rehabil. 2011;25:524–536. doi:10.1177/0269215510391682
  • Goldstein RS. Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax. 2005;60:889–890. doi:10.1136/thx.2005.043810
  • O’Neill K, O’Donnell AE, Bradley JM. Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis. Respirology. 2019;24:227–237. doi:10.1111/resp.13459
  • Liu ZX, Peng L. Impact of lung function and exercise endurance in chronic obstructive pulmonary disease patients treated with respiratory rehabilitation training. Modern Med J. 2014;42:615–618. doi:10.3969/j.issn.1671-7562.2014.06.006
  • Irvani SSN, Golmohammadi M, Pourhoseingholi MA, Shokouhi S, Darazam IA. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial. Trials. 2020;21(1):473. doi:10.1186/s13063-020-04382-3
  • Stanford G, Davies JC, Usmani O, et al. Investigating outcome measures for assessing airway clearance techniques in adults with cystic fibrosis: protocol of a single-centre randomised controlled crossover trial. BMJ Open Respir Res. 2020;7(1):e000694. doi:10.1136/bmjresp-2020-000694
  • du Bois RM, Albera C, Bradford WZ, et al. 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2014;43(5):1421–1429. doi:10.1183/09031936.00131813
  • Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61–65.
  • Liu J, Lin CS, Gan WQ, et al. Effect of healthcare insurance policy on the quality of life of chronic hepatitis C patients receiving interferon α-2a plus ribavirin therapy. Exp Ther Med. 2012;3:1062–1066. doi:10.3892/etm.2012.519
  • Lv Y, Guo S, Li XG, Chi JY, Qu YQ, Zhong HL. Sputum and serum microRNA-144 levels in patients with tuberculosis before and after treatment. Int J Infect Dis. 2016;43:68–73. doi:10.1016/j.ijid.2015.12.014
  • Daviskas E, Anderson DS, Jaques A, Charlton B. Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis. Chest. 2010;137(4):861–868. doi:10.1378/chest.09-2017
  • Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131:4S–42S. doi:10.1378/chest.06-2418
  • Patel S, Cole AD, Nolan CM, et al. Pulmonary rehabilitation in bronchiectasis: a propensity-matched study. Eur Respir J. 2019;53:1801264. doi:10.1183/13993003.01264-2018
  • Wada TJ, Borges-Santos E, Porras CD, et al. Effects of aerobic training combined with respiratory muscle stretching on the functional exercise capacity and thoracoabdominal kinematics in patients with COPD: a randomized and controlled trial. Int J Chron Obstruct Pulmon Dis. 2016;11:2691–2700. doi:10.2147/COPD.S114548
  • Elkins M, Dentice R. Inspiratory muscle training facilitates weaning from mechanical ventilation among patients in the intensive care unit: a systematic review. J Physiother. 2015;61:125–134. doi:10.1016/j.jphys.2015.05.016